During the past decade, Theodor Bilharz Research Institute conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 1 clinical trials were completed, i.e. on average, 5.9% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Theodor Bilharz Research Institute" #1 sponsor was "Theodor Bilharz Research Institute" with 15 trials, followed by "Abnoba Gmbh" with 2 trials sponsored, "Cairo University" with 1 trials sponsored, "Dr. Ahmed Ismail" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Theodor Bilharz Research Institute" #1 collaborator was "Cairo University" with 3 trials as a collaborator, "Theodor Bilharz Research Institute" with 2 trials as a collaborator, "Université Libre de Bruxelles" with 2 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "Cairo Kidney Center" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Theodor Bilharz Research Institute" are "Superficial Bladder Cancer" (2 trials), "Variceal Hemorrhage" (2 trials), "Airway Complication of Anaesthesia" (1 trials), "Anesthesia" (1 trials) and "Anesthesia; Adverse Effect, Spinal and Epidural" (1 trials). Many other conditions were trialed in "Theodor Bilharz Research Institute" in a lesser frequency.

Most popular intervention types in "Theodor Bilharz Research Institute" are "Drug" (13 trials), "Device" (5 trials), "Other" (3 trials), "Diagnostic Test" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Dexmedetomidine" (3 trials), "Placebo" (3 trials), "Desflurane" (2 trials), "Hemospray" (2 trials) and "Air-Q" (1 trials). Other intervention names were less common.

The vast majority of trials in "Theodor Bilharz Research Institute" are 19 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Theodor Bilharz Research Institute". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Theodor Bilharz Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Theodor Bilharz Research Institute, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 10 trials that are defined as “Not Applicable".